Get started
Cytosorbents CorporationCytosorbents CorporationCytosorbents Corporation

Cytosorbents Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

CTSO chart

Key stats

Market capitalization
‪45.53 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.6347USD
Net income
‪−28.51 M‬USD
Revenue
‪36.35 M‬USD
Shares float
‪45.74 M‬
Beta (1Y)
1.41

About Cytosorbents Corporation

Sector
Health Technology
Industry
Medical Specialties
CEO
Phillip P. Chan
Website
cytosorbents.com
Headquarters
Princeton
Employees (FY)
186
Founded
1997
ISIN
US23283X2062
FIGI
BBG000C3P8V0
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CTSO is 0.87 USD — it has decreased by 0.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cytosorbents Corporation stocks are traded under the ticker CTSO.
Cytosorbents Corporation is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Cytosorbents Corporation has a max estimate of 3.00 USD and a min estimate of 1.00 USD.
CTSO earnings for the last quarter are −0.21 USD whereas the estimation was −0.12 USD which accounts for −70.27% surprise. Estimated earnings for the next quarter are −0.14 USD. See more details about Cytosorbents Corporation earnings.
Cytosorbents Corporation revenue for the last quarter amounts to ‪8.81 M‬ USD despite the estimated figure of ‪9.50 M‬ USD. In the next quarter revenue is expected to reach ‪9.28 M‬ USD.
Yes, you can track Cytosorbents Corporation financials in yearly and quarterly reports right on TradingView.
Like other stocks, CTSO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cytosorbents Corporation stock right from TradingView charts — choose your broker and connect to your account.
CTSO reached its all-time high on Mar 24, 2015 with the price of 15.24 USD, and its all-time low was 0.84 USD and was reached on Jan 25, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 186.00 employees. See our rating of the largest employees — is Cytosorbents Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cytosorbents Corporation EBITDA is ‪−28.46 M‬ USD, and current EBITDA margin is −78.48%. See more stats in Cytosorbents Corporation financial statements.